Lexicon Pharmaceuticals, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Rok finansowy 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 5 14 306 35 43 62 76 73 50 32 11 5 2 1 2 23 130 83 90 63 322 24 0 0 1 31
Przychód Δ r/r 0.0% 207.6% 2013.5% -88.5% 21.7% 44.1% 22.6% -3.8% -31.2% -35.5% -66.9% -54.1% -62.3% -41.1% 104.0% 928.5% 468.9% -35.9% 8.4% -30.0% 409.5% -92.5% -98.8% -53.4% 766.2% 2481.5%
Marża brutto 142.6% 118.1% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 97.9% 96.1% 99.0% 92.0% -18371.8% -207.2% 92.9% 98.0%
EBIT (mln) -13 -35 -44 -63 -63 -47 -36 -55 -75 -97 -90 -96 -114 -108 -102 -100 1 -137 -137 -103 141 -179 -87 -101 -172 -197
EBIT Δ r/r 0.0% 177.2% 23.0% 44.1% -0.5% -24.2% -23.9% 52.9% 35.7% 28.8% -6.8% 6.4% 19.2% -5.0% -5.6% -2.0% -101.5% -9443.0% -0.3% -24.4% -237.0% -226.4% -51.3% 15.7% 70.5% 14.8%
EBIT (%) -272.3% -245.4% -14.3% -178.7% -146.1% -76.9% -47.7% -75.9% -149.6% -298.7% -840.7% -1950.2% -6170.6% -9955.5% -4607.2% -439.2% 1.1% -164.6% -151.3% -163.4% 43.9% -745.1% -29224.8% -72489.2% -14265.0% -634.2%
Koszty finansowe (mln) 0 0 0 0 0 3 3 3 3 3 3 3 3 2 2 2 7 7 7 21 21 15 1 3 13 16
EBITDA (mln) -11 -33 -27 -42 -41 -36 -25 -44 -64 -83 -89 -95 -114 -98 -104 -84 12 -136 -133 -100 173 -176 -87 -99 -163 -184
EBITDA(%) -229.8% -227.2% -8.9% -120.2% -95.9% -58.1% -33.1% -61.0% -127.2% -256.9% -832.5% -1939.7% -6156.8% -9018.4% -4696.9% -365.7% 8.9% -162.7% -146.8% -157.8% 53.8% -733.6% -29179.9% -71341.0% -13576.7% -592.9%
Podatek (mln) -0 -9 -8 -3 2 -0 0 -0 -16 -20 -0 -0 -2 -2 -1 -0 6 5 -13 4 -6 12 1 1 0 0
Zysk Netto (mln) -12 -26 -35 -60 -64 -47 -36 -54 -59 -77 -83 -102 -116 -110 -104 -100 -5 -141 -129 -121 130 -70 -88 -103 -177 -200
Zysk netto Δ r/r 0.0% 108.0% 35.3% 69.7% 7.6% -26.5% -23.0% 49.6% 8.3% 30.7% 7.7% 22.9% 14.2% -5.2% -5.5% -3.7% -95.3% 2920.7% -8.8% -6.6% -208.0% -153.9% 25.8% 16.8% 71.7% 13.1%
Zysk netto (%) -266.0% -179.8% -11.5% -169.5% -149.9% -76.4% -48.0% -74.6% -117.3% -237.8% -773.6% -2073.7% -6285.3% -10120.4% -4686.1% -438.8% -3.6% -169.7% -142.9% -190.7% 40.4% -292.5% -29620.1% -74192.8% -14710.9% -644.8%
EPS -3.57 -4.37 -4.9 -7.99 -7.91 -5.21 -3.97 -5.68 -4.12 -3.93 -3.98 -2.35 -2.39 -1.58 -1.42 -1.31 -0.0452 -1.36 -1.23 -1.14 1.23 -0.63 -0.61 -0.62 -0.8 -0.63
EPS (rozwodnione) -3.57 -4.37 -4.9 -7.99 -7.91 -5.21 -3.97 -5.68 -4.12 -3.93 -3.98 -2.35 -2.39 -1.58 -1.42 -1.31 -0.0452 -1.36 -1.23 -1.14 1.11 -0.63 -0.61 -0.62 -0.8 -0.63
Ilośc akcji (mln) 4 6 7 7 8 9 9 10 14 20 21 43 49 70 73 76 104 104 105 106 106 111 146 166 221 320
Ważona ilośc akcji (mln) 4 6 7 7 8 9 9 10 14 20 21 43 49 70 73 76 104 104 105 106 117 111 146 166 221 320
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD